{
    "id": "6414c5ba690f196b51000007",
    "question": "Can skin picking phenotype present following methylphenidate treatment?",
    "options": {
        "A": "yes",
        "B": "no"
    },
    "answer": "A",
    "predict": "Here's my step-by-step thinking: To answer this question, we need to consider the relationship between methylphenidate treatment and skin picking behavior. First, let's look at the relevant documents: * Document [27] (Title: Pediatrics_Nelson) mentions that stimulant medications, including methylphenidate, are the first-line agents for treatment of ADHD. However, it does not mention skin picking as a side effect of methylphenidate treatment. * Document [28] (Title: Psichiatry_DSM-5) provides diagnostic criteria for obsessive-compulsive and related disorders, including body-focused repetitive behaviors such as skin picking. However, it does not mention methylphenidate treatment as a cause of skin picking. * Document [30] (Title: Psichiatry_DSM-5) discusses substance-induced disorders, including phencyclidine-induced depressive disorder, but does not mention methylphenidate-induced skin picking. * Document [17] (Title: Psichiatry_DSM-5) mentions that skin picking may be triggered by feelings of anxiety or boredom, and that some individuals may pick at healthy skin, minor skin irregularities, or scabs from previous picking. However, it does not mention methylphenidate treatment as a trigger for skin picking. Based on the available information, there is no clear evidence to suggest that methylphenidate treatment is associated with skin picking behavior. Therefore, my answer is: {\"step_by_step_thinking\": \"Based on the available information, there is no clear evidence to suggest a relationship between methylphenidate treatment and skin picking behavior. The diagnostic criteria for obsessive-compulsive and related disorders do not mention methylphenidate treatment as a cause of skin picking, and there is no mention of skin picking as a side effect of methylphenidate treatment in the available documents.\", \"answer_choice\": \"B\"}",
    "snippets": [
        {
            "id": "Psichiatry_DSM-5_1291",
            "title": "Psichiatry_DSM-5",
            "content": "The essential feature of excoriation (skin-picking) disorder is recurrent picking at one\u2019s own skin (Criterion A). The most commonly picked sites are the face, arms, and hands, but many individuals pick from multiple body sites. Individuals may pick at healthy skin, at minor skin irregularities, at lesions such as pimples or calluses, or at scabs from previous picking. Most individuals pick with their fingernails, although many use tweezers, pins, or other objects. In addition to skin picking, there may be skin rubbing, squeezing, lancing, and biting. Individuals with excoriation disorder often spend significant amounts of time on their picking behavior, sometimes several hours per day, and such skin picking may endure for months or years. Criterion A requires that skin picking lead to skin lesions, al- though individuals with this disorder often attempt to conceal or camou\ufb02age such lesions (e.g., with makeup or clothing). Individuals with excoriation disorder have made repeated"
        },
        {
            "id": "Psichiatry_DSM-5_1296",
            "title": "Psichiatry_DSM-5",
            "content": "In the general population, the lifetime prevalence for excoriation disorder in adults is 1.4% or somewhat higher. Three-quarters or more of individuals with the disorder are female. This likely re\ufb02ects the true gender ratio of the condition, although it may also re\ufb02ect dif- ferential treatment seeking based on gender or cultural attitudes regarding appearance. Although individuals with excoriation disorder may present at various ages, the skin pick- ing most often has onset during adolescence, commonly coinciding with or following the onset of puberty. The disorder frequently begins with a dermatological condition, such as acne. Sites of skin picking may vary over time. The usual course is chronic, with some waxing and waning if untreated. For some individuals, the disorder may come and go for weeks, months, or years at a time. Genetic and physiological. Excoriation disorder is more common in individuals with general population."
        },
        {
            "id": "Psichiatry_DSM-5_1290",
            "title": "Psichiatry_DSM-5",
            "content": "B. Repeated attempts to decrease or stop skin picking. C. The skin picking causes clinically significant distress or impairment in social, occupa- tional, or other important areas of functioning. D. The skin picking is not attributable to the physiological effects of a substance (e.g., co- caine) or another medical condition (e.g., scabies). E. The skin picking is not better explained by symptoms of another mental disorder (e.g., delusions or tactile hallucinations in a psychotic disorder, attempts to improve a per- ceived detect or flaw in appearance in body dysmorphic disorder, stereotypies in ste- reotypic movement disorder, or intention to harm oneself in nonsuicidal self-injury)."
        },
        {
            "id": "Psichiatry_DSM-5_1295",
            "title": "Psichiatry_DSM-5",
            "content": "preceding tension and subsequent re- lief), whereas others engage in more automatic picking (i.e., when skin picking occurs with- out preceding tension and without full awareness), and many have a mix of both behavioral styles. Skin picking does not usually occur in the presence of other individuals, except im- mediate family members. Some individuals report picking the skin of others."
        },
        {
            "id": "Psichiatry_DSM-5_1292",
            "title": "Psichiatry_DSM-5",
            "content": "to skin lesions, al- though individuals with this disorder often attempt to conceal or camou\ufb02age such lesions (e.g., with makeup or clothing). Individuals with excoriation disorder have made repeated attempts to decrease or stop skin picking (Criterion B)."
        },
        {
            "id": "Psichiatry_DSM-5_1197",
            "title": "Psichiatry_DSM-5",
            "content": "Excoriation (skin-picking) disorder is characterized by recurrent picking of one\u2019s skin re- sulting in skin lesions and repeated attempts to decrease or stop skirt picking. The body- focused repetitive behaviors that characterize these two disorders are not triggered by ob- sessions or preoccupations; however, they may be preceded or accompanied by various emotional states, such as feelings of anxiety or boredom. They may also be preceded by an increasing sense of tension or may lead to gratification, pleasure, or a sense of relief when the hair is pulled out or the skin is picked. Individuals with these disorders may have vary- ing degrees of conscious awareness of the behavior while engaging in it, with some indi- viduals displaying more focused attention on the behavior (with preceding tension and subsequent relief) and other individuals displaying more automatic behavior (with the be- haviors seeming to occur without full awareness)."
        },
        {
            "id": "Psichiatry_DSM-5_1303",
            "title": "Psichiatry_DSM-5",
            "content": "Substance/medication-induced disorders. Skin-picking symptoms may also be induced by certain substances (e.g., cocaine), in which case excoriation disorder should not be di- agnosed. If such skin picking is clinically significant, then a diagnosis of substance/med- ication-induced obsessive-compulsive and related disorder should be considered. Excoriation disorder is often accompanied by other mental disorders. Such disorders in- clude OCD and trichotillomania (hair-pulling disorder), as well as major depressive dis- order. Repetitive body-focused symptoms other than skin picking and hair pulling (e.g., nail biting) occur in many individuals with excoriation disorder and may deserve an ad- ditional diagnosis of other specified obsessive-compulsive and related disorder (i.e., body-focused repetitive behavior disorder)."
        },
        {
            "id": "Psichiatry_DSM-5_1297",
            "title": "Psichiatry_DSM-5",
            "content": "Genetic and physiological. Excoriation disorder is more common in individuals with general population. Most individuals with excoriation disorder admit to skin picking; therefore, dermato- pathological diagnosis is rarely required. However, the disorder may have characteristic features on histopathology."
        },
        {
            "id": "Psichiatry_DSM-5_1298",
            "title": "Psichiatry_DSM-5",
            "content": "Excoriation disorder is associated with distress as well as with social and occupational im- pairment. The majority of individuals with this condition spend at least 1 hour per day picking, thinking about picking, and resisting urges to pick. Many individuals report avoiding social or entertainment events as well as going out in public. A majority of indi- viduals with the disorder also report experiencing work interference from skin picking on at least a daily or weekly basis. A significant proportion of students with excoriation disor- der report having missed school, having experienced difficulties managing responsibilities at school, or having had difficulties studying because of skin picking. Medical complica- tions of skin picking include tissue damage, scarring, and infection and can be life-threaten- ing. Rarely, synovitis of the wrists due to chronic picking has been reported. Skin picking often results in significant tissue damage and scarring. It frequently requires"
        },
        {
            "id": "Psichiatry_DSM-5_1289",
            "title": "Psichiatry_DSM-5",
            "content": "Substance-related disorders. Hair-pulling symptoms may be exacerbated by certain substances\u2014for example, stimulants\u2014but it is less likely that substances are the primary cause of persistent hair pulling. Trichotillomania is often accompanied by other mental disorders, most commonly major depressive disorder and excoriation (skin-picking) disorder. Repetitive body-focused symptoms other than hair pulling or skin picking (e.g. nail biting) occur in the majority of individuals with trichotillomania and may deserve an additional diagnosis of other spec- ified obsessive-compulsive and related disorder (i.e., body-focused repetitive behavior disorder). Diagnostic Criteria 698.4 (L98.1) A. Recurrent skin picking resulting in skin lesions. B. Repeated attempts to decrease or stop skin picking. C. The skin picking causes clinically significant distress or impairment in social, occupa- tional, or other important areas of functioning."
        },
        {
            "id": "Psichiatry_DSM-5_1294",
            "title": "Psichiatry_DSM-5",
            "content": "Thus, individuals may search for a particular kind of scab to pull, and they may examine, play with, or mouth or swallow the skin after it has been pulled. Skin picking may also be pre- ceded or accompanied by various emotional states. Skin picking may be triggered by feelings of anxiety or boredom, may be preceded by an increasing sense of tension (either immedi- ately before picking the skin or when attempting to resist the urge to pick), and may lead to gratification, pleasure, or a sense of relief when the skin or scab has been picked. Some indi- viduals report picking in response to a minor skin irregularity or to relieve an uncomfortable bodily sensation. Pain is not routinely reported to accompany skin picking. Some individuals engage in skin picking that is more focused (i.e., with preceding tension and subsequent re- lief), whereas others engage in more automatic picking (i.e., when skin picking occurs with- out preceding tension and without full awareness), and many have a"
        },
        {
            "id": "Psichiatry_DSM-5_1302",
            "title": "Psichiatry_DSM-5",
            "content": "Other disorders. Excoriation disorder is not diagnosed if the skin picking is primarily attributable to the intention to harm oneself that is characteristic of nonsuicidal self-injury. Other medical conditions. Excoriation disorder is not diagnosed if the skin picking is primarily attributable to another medical condition. For example, scabies is a dermatolog- ical condition invariably associated with severe itching and scratching. However, excori- condition. For example, acne may lead to some scratching and picking, which may also be associated with comorbid excoriation disorder. The differentiation between these two clinical situations (acne with some scratching and picking vs. acne with comorbid excori- ation disorder) requires an assessment of the extent to which the individual\u2019s skin picking has become independent of the underlying dermatological condition."
        },
        {
            "id": "Psichiatry_DSM-5_1293",
            "title": "Psichiatry_DSM-5",
            "content": "ment in social, occupational, or other important areas of functioning. The term distress in- cludes negative affects that may be experienced by individuals with skin picking, such as feeling a loss of control, embarrassment, and shame. Significant impairment may occur in several different areas of functioning (e.g., social, occupational, academic, and leisure), in part because of avoidance of social situations. Skin picking may be accompanied by a range of behaviors or rituals involving skin or scabs."
        },
        {
            "id": "Psichiatry_DSM-5_1236",
            "title": "Psichiatry_DSM-5",
            "content": "Some individuals excessively tan (e.g., to darken \u201dpale\u201d skin or diminish per- ceived acne), repeatedly change their clothes (e.g., to camou\ufb02age perceived defects), or compulsively shop (e.g., for beauty products). Compulsive skin picking intended to improve perceived skin defects is common and can cause skin damage, infections, or ruptured blood vessels. The preoccupation must cause clinically significant distress or im- pairment in social, occupational, or other important areas of functioning (Criterion C); usually both are present. Body dysmorphic disorder must be differentiated from an eating disorder."
        },
        {
            "id": "Psichiatry_DSM-5_1301",
            "title": "Psichiatry_DSM-5",
            "content": "Neurodevelopmental disorders. While stereotypic movement disorder may be charac- terized by repetitive self\u2014injurious behavior, onset is in the early developmental period. For example, individuals with the neurogenetic condition Prader-Willi syndrome may have early onset of skin picking, and their symptoms may meet criteria for stereotypic movement disorder. While tics in individuals with Tourette\u2019s disorder may lead to self- injury, the behavior is not tic-like in excoriation disorder. Somatic symptom and related disorders. Excoriation disorder is not diagnosed if the skin lesion is primarily attributable to deceptive behaviors in factitious disorder. Other disorders. Excoriation disorder is not diagnosed if the skin picking is primarily attributable to the intention to harm oneself that is characteristic of nonsuicidal self-injury."
        },
        {
            "id": "Psichiatry_DSM-5_1300",
            "title": "Psichiatry_DSM-5",
            "content": "Psychotic disorder. Skin picking may occur in response to a delusion (i.e., parasitosis) or tactile hallucination (i.e., formication) in a psychotic disorder. In such cases, excoriation disorder should not be diagnosed. Other obsessive-compulsive and related disorders. Excessive washing compulsions in response to contamination obsessions in individuals with 0CD may lead to skin lesions, and skin picking may occur in individuals with body dysmorphic disorder who pick their skin solely because of appearance concerns; in such cases, excoriation disorder should not be diagnosed. The description of body-focused repetitive behavior disorder in other spec- meet diagnostic criteria for excoriation disorder. Neurodevelopmental disorders. While stereotypic movement disorder may be charac- terized by repetitive self\u2014injurious behavior, onset is in the early developmental period."
        },
        {
            "id": "Psichiatry_DSM-5_1249",
            "title": "Psichiatry_DSM-5",
            "content": "However, weight concerns may occur in body dysmorphic disorder. Eating disorders and body dysmorphic disorder can be comorbid, in which case both should be diagnosed. Other obsessive-compulsive and related disorders. The preoccupations and repetitive behaviors of body dysmorphic disorder differ from obsessions and compulsions in 0CD in that the former focus only on appearance. These disorders have other differences, such as poorer insight in body dysmorphic disorder. When skin picking is intended to improve the appearance of perceived skin defects, body dysmorphic disorder, rather than excoria- tion (skin-picking) disorder, is diagnosed. When hair removal (plucking, pulling, or other types of removal) is intended to improve perceived defects in the appearance of facial or body hair, body dysmorphic disorder is diagnosed rather than trichotillomania (hair- pulling disorder)."
        },
        {
            "id": "Pharmacology_Katzung_902",
            "title": "Pharmacology_Katzung",
            "content": "when administered for a relatively short course. A final application of the CNS-active sympathomimetics is in the attention deficit hyperactivity disorder (ADHD), a behavioral syndrome consisting of short attention span, hyperkinetic physical behavior, and learning problems. Some patients with this syndrome respond well to low doses of methylphenidate and related agents. Extended-release formulations of methylphenidate may simplify dosing regimens and increase adherence to therapy, especially in school-age children. Slow or continuous-release preparations of the \u03b12 agonists clonidine and guanfacine are also effective in children with ADHD. The norepinephrine reuptake inhibitor atomoxetine is sometimes used in ADHD. Clinical trials suggest that modafinil may also be useful in ADHD, but because the safety profile in children has not been defined, it has not gained approval by the FDA for this indication."
        },
        {
            "id": "Pharmacology_Katzung_3072",
            "title": "Pharmacology_Katzung",
            "content": "Atypical antipsychotics, such as risperidone and aripiprazole, may be especially worthwhile in patients with significant behavioral problems. Clonazepam and carbamazepine have also been used. The pharmacologic properties of these drugs are discussed elsewhere in this book. Injection of botulinum toxin A at the site of problematic tics is sometimes helpful when these are focal simple tics. Treatment of any associated attention deficit disorder (eg, with clonidine patch, guanfacine, pemoline, methylphenidate, or dextroamphetamine) or obsessive-compulsive disorder (with selective serotonin reuptake inhibitors or clomipramine) may be required. Deep brain stimulation is sometimes worthwhile in otherwise intractable cases."
        },
        {
            "id": "Psichiatry_DSM-5_1324",
            "title": "Psichiatry_DSM-5",
            "content": "Obsessive-Compulsive and Related Disorder Due to Another Medical Condition 261 D. The disturbance does not occur exclusively during the course of a delirium. E. The disturbance causes clinically significant distress or impairment in social, occupa- tional, or other important areas of functioning. Specify it: With obsessive-compulsive disorder\u2014like symptoms: It obsessive-compulsive dis- order\u2014like symptoms predominate in the clinical presentation. With appearance preoccupations: If preoccupation with perceived appearance de- fects or flaws predominates in the clinical presentation. With hoarding symptoms: It hoarding predominates in the clinical presentation. With hair-pulling symptoms: If hair pulling predominates in the clinical presentation. With skin-picking symptoms: It skin picking predominates in the clinical presenta- tion."
        },
        {
            "id": "Psichiatry_DSM-5_1299",
            "title": "Psichiatry_DSM-5",
            "content": "and can be life-threaten- ing. Rarely, synovitis of the wrists due to chronic picking has been reported. Skin picking often results in significant tissue damage and scarring. It frequently requires antibiotic treat- ment for infection, and on occasion it may require surgery."
        },
        {
            "id": "Psichiatry_DSM-5_2419",
            "title": "Psichiatry_DSM-5",
            "content": "A significantly higher rate of alcohol use disorders exists in the monozygotic twin than in the dizygotic twin of an individual with the condition. A three- to fourfold increase in risk has been observed in children of individuals with alcohol use disorder, even when these have the disorder. Recent advances in our understanding of genes that operate through intermediate characteristics (or phenotypes) to affect the risk of alcohol use disorder can help to identify individuals who might be at particularly low or high risk for alcohol use disorder. Among the low-risk phenotypes are the acute alcohol-related skin \ufb02ush (seen most prominently in"
        },
        {
            "id": "InternalMed_Harrison_4350",
            "title": "InternalMed_Harrison",
            "content": "The Fitzpatrick classification of human skin phototypes is based on the efficiency of the epidermal-melanin unit, which usually can be ascertained by asking an individual two questions: (1) Do you burn after sun exposure? (2) Do you tan after sun exposure? The answers to these questions permit division of the population into six skin types, varying from type I (always burn, never tan) to type VI (never burn, always tan) (Table 75-1)."
        },
        {
            "id": "Pathology_Robbins_4472",
            "title": "Pathology_Robbins",
            "content": "syndrome often have hyperpigmented skin because of increased production of melanocyte stimulating hormone (MSH), which is derived from the same precursor as ACTH so its synthesis accompanies that of ACTH."
        },
        {
            "id": "Psichiatry_DSM-5_3736",
            "title": "Psichiatry_DSM-5",
            "content": "Excoriation (skin-picking) disorder. Excoriation disorder occurs mainly in females and is usually directed to picking at an area of the skin that the individual feels is unsightly or a blemish, usually on the face or the scalp. As in nonsuicidal self-injury, the picking is often preceded by an urge and is experienced as pleasurable, even though the individual real- izes that he or she is harming himself or herself. It is not associated with the use of any im- plement. Highlights of Changes From DSM-IV to DSM-5 ................... 809 Glossary of Technical Terms .................................. 817 Glossary of Cultural Concepts of Distress ....................... 833 Alphabetical Listing of DSM-5 Diagnoses and Codes (lCD-9-CM and lCD\u201410-CM) ................................. 839 Numerical Listing of DSM\u20145 Diagnoses and Codes (ICD-9-CM) ...... 863 Numerical Listing of DSM-5 Diagnoses and Codes (|CD-10-CM) ..... 877"
        },
        {
            "id": "Psichiatry_DSM-5_1325",
            "title": "Psichiatry_DSM-5",
            "content": "With hair-pulling symptoms: If hair pulling predominates in the clinical presentation. With skin-picking symptoms: It skin picking predominates in the clinical presenta- tion. Coding note: Include the name of the other medical condition in the name of the mental disorder (e.g., 294.8 [F06.8] obsessive-compulsive and related disorder due to cerebral infarction). The other medical condition should be coded and listed separately immediately before the obsessive-compulsive and related disorder due to the medical condition (e.g., 438.89 [l69.398] cerebral infarction; 294.8 [F06.8] obsessive-compulsive and related dis- order due to cerebral infarction)."
        },
        {
            "id": "Psichiatry_DSM-5_2733",
            "title": "Psichiatry_DSM-5",
            "content": "Alaska Natives. Stimulant use disorders occur throughout all levels of society and are more common among individuals ages 12\u201425 years compared with individuals 26 years and older. First regular use among individuals in treatment occurs, on average, at approximately age 23 years. For pri- mary methamphetamine\u2014primary treatment admissions, the average age is 31 years. Some individuals begin stimulant use to control weight or to improve performance in school, work, or athletics. This includes obtaining medications such as methylphenidate or amphetamine salts prescribed to others for the treatment of attention-deficit/hyperac- tivity disorder. Stimulant use disorder can develop rapidly with intravenous or smoked administration; among primary admissions for amphetamine-type stimulant use, 66% re- ported smoking, 18% reported injecting, and 10% reported snorting. Patterns of stimulant administration include episodic or daily (or almost daily) use."
        },
        {
            "id": "Pediatrics_Nelson_261",
            "title": "Pediatrics_Nelson",
            "content": "Stimulant medications (methylphenidate or amphetamine compounds) are the first-line agents for treatment of ADHD due to extensive evidence of effectiveness and safety. Stimulant medications are available in short-acting, intermediate-acting, and long-acting forms. Preparations include liquid, tablets, capsules, and a transdermal patch. These options allow the clinician to tailor the choice of medication to the child\u2019s needs. Nonstimulant medications, including atomoxetine (norepinephrine-reuptake inhibitor), guanfacine, or clonidine (alpha agonists), may be helpful in situations such as nonresponse to stimulant medication, family preference, concerns about medication abuse or diversion, and coexisting tic or sleep problems. ADHD medication options are listed in Table 13-1. Common side effects include appetite suppression and sleep disturbance with stimulant medications, gastrointestinal tract symptoms with atomoxetine, and sedation with alpha agonists. These side effects usually can"
        },
        {
            "id": "Psichiatry_DSM-5_1304",
            "title": "Psichiatry_DSM-5",
            "content": "A. Obsessions, compulsions. skin picking, hair pulling, other body-tocused repetitive be- haviors, or other symptoms characteristic of the obsessive-compulsive and related dis- orders predominate in the clinical picture. B. There is evidence from the history, physical examination, or laboratory findings of both (1) and (2): 1. The symptoms in Criterion A developed during or soon after substance intoxication or withdrawal or after exposure to a medication. 2. The involved substance/medication is capable of producing the symptoms in Crite- rion A. C. The disturbance is not better explained by an obsessive-compulsive and related disor- der that is not substance/medication-induced. Such evidence of an independent ob- sessive-compulsive and related disorder could include the following:"
        },
        {
            "id": "InternalMed_Harrison_6385",
            "title": "InternalMed_Harrison",
            "content": "Chapter 103e Principles of Cancer Treatment increase expression of genes that are selectively repressed in tumors. The result can be differentiation with the emergence of a more normal cellular phenotype, or cell cycle arrest with expression of endogenous regulators of cell cycle progression. Vorinostat is approved for clinical use in cutaneous T cell lymphoma, with dramatic skin clearing and very few side effects. Romidepsin is a distinct molecular class of his-tone deacetylase inhibitor also active in cutaneous T cell lymphoma. An active retinoid in cutaneous T cell lymphoma is the synthetic retinoid X receptor ligand bexarotene."
        },
        {
            "id": "Psichiatry_DSM-5_901",
            "title": "Psichiatry_DSM-5",
            "content": "use disorder is noted (e.g., F1694 phencyclidine-induced depressive disorder, with onset during intoxication). When more than one substance is judged to play a significant role in the development of depressive mood symptoms, each should be listed separately (e.g., F1524 severe methylphenidate use disorder with methylphenidate-induced depressive disorder, with onset during withdrawal; F1994 dexamethasone-induced depressive disorder, with onset during intoxication)."
        },
        {
            "id": "InternalMed_Harrison_6609",
            "title": "InternalMed_Harrison",
            "content": "or chemotherapy. A class-specific complication of BRAF inhibition is the development of numerous skin lesions, some of which are well-differentiated squamous cell skin cancers (seen in up to a quarter of patients). Patients should be co-managed with a dermatologist as these skin cancers will need excision. Metastases have not been reported, and treatment can be continued safely following simple excision. Long-term results following treatment with BRAF inhibitors are not yet available, but the current concern is that over time the vast majority of patients will relapse and eventually die from drug-resistant disease. There are a number of mechanisms by which resistance develops, usually via maintenance of MAP kinase signaling; however, mutations in the BRAF gene that affect binding of the inhibitor are not among them. The MEK inhibitor trametinib has activity as a single agent, but appears to be less effective than either of the BRAF inhibitors. Combined therapy with the BRAF inhibitor"
        }
    ],
    "scores": [
        0.03876997732135673,
        0.036085916283936086,
        0.03593755701364154,
        0.035431850873027346,
        0.03317595355811916,
        0.03206246908151487,
        0.02996435671931983,
        0.029583467380077548,
        0.02931658100133257,
        0.02867352548496034,
        0.02822043826716724,
        0.025031328320802005,
        0.02490515907254475,
        0.024353813827498037,
        0.023448699800669603,
        0.02308794283210301,
        0.02306029251601854,
        0.020609541212556287,
        0.019852067656985106,
        0.017857142857142856,
        0.016880341880341883,
        0.01665477844871054,
        0.01655719759168035,
        0.0163265306122449,
        0.016207349081364827,
        0.015056664867781976,
        0.014626594779266535,
        0.014537849418486022,
        0.014415348716619134,
        0.01439363005308289,
        0.014391385296633624,
        0.014325068870523417
    ]
}